Colposcope Market Insights: Key Players Shaping Competitive Landscape and Strategies
The global colposcope market size is expected to reach USD 537.08 million by 2030, registering a CAGR of 4.6% during the forecast period, according to a new report by Grand View Research, Inc. Increase in the prevalence of cervical cancer, technological advancements, and the rising demand for early- diagnosis of gynecological disorders are expected to boost the market growth. According to the ICO Information Centre on HPV and Cancer, cervical cancer is the fourth most frequent cancer among women globally, with an estimated 604,127 new cases and 341,831 deaths in 2020.
An article published by the Human Papillomavirus Information Center stated that cervical cancer is reported to be the second most common cancer among women aged 15 to 44. Colposcopy helps in accurate identification of cervical pre-cancer and early invasive cancer. Moreover, colposcope directed biopsies of severe lesion visualized help in further management of the disease. Growing awareness and rise in the number of screening campaigns for cervical cancer conducted by governments of various regions are expected to fuel the market growth during the forecast period.
Gather more insights about the market drivers, restrains and growth of the Global Colposcope Market
In the U.S., National Breast and Cervical Cancer Early Detection Program (NBCCEDP) offers breast and cervical cancer screening and diagnostic services to low-income, uninsured, and underinsured women across the country. Several obstacles arose as a result of the COVID-19 pandemic, including logistical constraints, low demand, and reduced sales and marketing activities. However, by mid-2022, the market is predicted to be steadily improving. By encouraging end-users to embrace high-end technologies for early diagnosis of the disease, aiming to lessen cervical cancer cases by 70%, and thus preventing over 4.5 million deaths (Source: WHO). This is expected to significantly boost the market in the coming years.
Colposcope Market Report Highlights
- The optical colposcopy segment dominated the market and is further expected to continue its dominance over the forecast period, as the adoption of optical colposcope is high in developing regions
- The video colposcope segment is expected to grow at the fastest rate during the forecast period
- Based on application, the oral examination segment is expected to grow the fastest rate during the forecast period.
- Based on portability, the handheld segment is estimated to register the fastest growth rate during the forecast period, owing to its ease of use and compact nature
- The hospital segment held the largest revenue share based on end-use in 2023
- North America dominated the market and accounted for the largest revenue share in 2023
- In Asia Pacific, the market is anticipated to witness the fastest CAGR over the forecast period owing to the growing need for technologically advanced and cost-effective healthcare solutions
Regional Insights
North America dominated the market in 2023 with the largest revenue share of 34.48%, owing to an increase in the prevalence of cervical cancer and a rise in healthcare expenditure. Factors such as the adoption of colposcope equipment, easy access to healthcare technologies, and significant distribution channels are expected to boost market growth. According to the Centers for Medicare and Medicaid Services, the U.S. government spent nearly USD 4.5 trillion on healthcare in 2022, accounting for approximately 17.3% of the total GDP.
List of Key Players of Colposcope Market
- Kaps GmbH & Co. KG
- Carl Zeiss Meditec AG
- CooperSurgical, Inc
- DYSIS Medical Inc
- ATMOS Medizin Technik GmbH & Co. KG
- Olympus Corporation
- McKesson Medical-Surgical Inc.
- Ecleris
- Optomic
- Seiler Instrument Inc.
Order a free sample PDF of the Colposcope Market Intelligence Study, published by Grand View Research.
English
Arabic
Français
Español
Português
Deutsch
Dutch
Italiano
Russian
Romaian